SSR97225

· Sanofi

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SSR97225, covering 2009-04-17 to 2009-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer [Phase 1]